These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2651867

  • 1. New findings in obsessive-compulsive disorder.
    Kim SW, Dysken MW.
    Minn Med; 1989 Feb; 72(2):91-3, 110. PubMed ID: 2651867
    [Abstract] [Full Text] [Related]

  • 2. Serotonin selectivity for obsessive compulsive and panic disorders.
    Montgomery SA, Bullock T, Fineberg N.
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):30-5. PubMed ID: 1931935
    [No Abstract] [Full Text] [Related]

  • 3. Symptom relapse in bulimia nervosa and obsessive compulsive disorder after treatment with serotonin antagonists.
    Hollander E, Mullen LS, Carrasco JL, DeCaria CM, Stein DJ.
    J Clin Psychiatry; 1992 Jan; 53(1):28. PubMed ID: 1737737
    [No Abstract] [Full Text] [Related]

  • 4. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP, Miller JA, Sheehan DV, Fanous BS.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
    [Abstract] [Full Text] [Related]

  • 5. Serotonin and treatment in obsessive-compulsive disorder.
    March JS, Gutzman LD, Jefferson JW, Greist JH.
    Psychiatr Dev; 1989 Aug; 7(1):1-18. PubMed ID: 2508084
    [Abstract] [Full Text] [Related]

  • 6. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K, Aoki M.
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 9. Obsessive-compulsive disorder and its treatment with serotonin-selective agents.
    Murphy DL, Pigott TA.
    Prog Clin Biol Res; 1990 Oct; 361():179-201. PubMed ID: 2290841
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Drug treatment of compulsive disorder].
    Rapoport JL.
    Nervenarzt; 1991 May; 62(5):318-20. PubMed ID: 1865964
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L, Topuz A.
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 5-HT2c receptor activation induces grooming behaviour in rats: possible correlations with obsessive-compulsive disorder.
    Gráf M.
    Neuropsychopharmacol Hung; 2006 Mar; 8(1):23-8. PubMed ID: 16841562
    [Abstract] [Full Text] [Related]

  • 19. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C, Millet B, Olie JP.
    Encephale; 2000 Mar; 26(2):81-8. PubMed ID: 10858921
    [Abstract] [Full Text] [Related]

  • 20. Serotonergic antidepressants and obsessive-compulsive disorder.
    Cialdella P, Boissel JP.
    Am J Psychiatry; 1991 Oct; 148(10):1415-6. PubMed ID: 1832819
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.